Filter Results:
(1,338)
Show Results For
- All HBS Web
(5,440)
- Faculty Publications (1,338)
Show Results For
- All HBS Web
(5,440)
- Faculty Publications (1,338)
- February 20, 2014
- Article
Today's Neighborhood Drugstore Is Tomorrow's Neighborhood Health Care Company
By: Nancy F. Koehn
Koehn, Nancy F. "Today's Neighborhood Drugstore Is Tomorrow's Neighborhood Health Care Company." Leadership Forum (February 20, 2014).
- February 2014 (Revised July 2016)
- Case
Iora Health
By: William A. Sahlman and Vineeta Vijayaraghavan
The Iora Health case looks at a new approach to the management and delivery of primary care. Instead of having a doctor, half a nurse and two accountants, Iora deploys a doctor, a nurse and several health coaches, all operating as an integrated team. Iora focuses on... View Details
Keywords: Management; Service Delivery; Groups and Teams; Financing and Loans; Health Care and Treatment; Health Industry
Sahlman, William A., and Vineeta Vijayaraghavan. "Iora Health." Harvard Business School Case 814-030, February 2014. (Revised July 2016.)
- January 2014 (Revised March 2014)
- Teaching Note
Cancer Screening in Japan: Market Research and Segmentation
By: John A. Quelch
- 2014
- Working Paper
Management Practices, Relational Contracts and the Decline of General Motors
By: Susan Helper and Rebecca Henderson
General Motors was once regarded as one of the best managed and most successful firms in the world, but between 1980 and 2009 its share of the US market fell from 62.6 to 19.8 percent, and in 2009 the firm went bankrupt. In this paper we argue that the conventional... View Details
Keywords: Organizational Change and Adaptation; Management Practices and Processes; Organizational Structure; Decision Making; Insolvency and Bankruptcy; Manufacturing Industry; Auto Industry
Helper, Susan, and Rebecca Henderson. "Management Practices, Relational Contracts and the Decline of General Motors." Harvard Business School Working Paper, No. 14-062, January 2014. (NBER Working Paper Series, No. 19867, January 2014.)
- January 2014 (Revised June 2014)
- Case
23andMe: Genetic Testing for Consumers (A)
By: John A. Quelch and Margaret L. Rodriguez
On November 22, 2013, the direct-to-consumer genetic testing provider, 23andMe, received a letter from the U.S. Food and Drug Administration (FDA) ordering the company to halt the sale and promotion of its genetic testing kit. The FDA stated that the product was... View Details
Keywords: Public Health; Genome Testing; Health Care; Ancestry; 23andMe; Marketing; Product Launch; Health; Health Care and Treatment; Health Testing and Trials; Genetics; Strategy; Health Industry; United States
Quelch, John A., and Margaret L. Rodriguez. "23andMe: Genetic Testing for Consumers (A)." Harvard Business School Case 514-086, January 2014. (Revised June 2014.)
- January 2014 (Revised June 2014)
- Supplement
23andMe: Genetic Testing for Consumers (B)
By: John A. Quelch and Margaret L. Rodriguez
Following the FDA's letter in November 2013, which ordered 23andMe to cease sales of its DNA test kits, observers wondered how co-founder and CEO, Anne Wojcicki, would guide the company in the presence of uncertainty. View Details
Keywords: Risk and Uncertainty; Genetics; Crisis Management; Health Care and Treatment; Product Development; Business and Government Relations; Biotechnology Industry; Consumer Products Industry; United States
Quelch, John A., and Margaret L. Rodriguez. "23andMe: Genetic Testing for Consumers (B)." Harvard Business School Supplement 514-095, January 2014. (Revised June 2014.)
- 24 Jan 2014
- Other Presentation
Value Based Health Care Delivery
According to Harvard professor Michael Porter, health care reform is proving to be one of the defining issues of the 21st century, both in the United States and throughout the world. Costs are exploding even in single-payer systems driven by aging populations and... View Details
Porter, Michael E. "Value Based Health Care Delivery." Harvard Kennedy School, Center for Public Leadership, Cambridge, MA, January 24, 2014.
- 22 Jan 2014
- Lecture
Value Based Health Care Delivery: Applications
Porter, Michael E. "Value Based Health Care Delivery: Applications." Lecture at the A Strategy to Fix Healthcare, Reform, London, England, January 22, 2014.
- 22 Jan 2014
- Other Presentation
Value-Based Health Care Delivery
Keywords: Health
Porter, Michael E. "Value-Based Health Care Delivery." A Strategy to Fix Healthcare, Reform, London, England, January 22, 2014.
- January 2014
- Supplement
Fred Khosravi and AccessClosure (C)
By: Richard Hamermesh and Lauren Barley
On September 11, 2013, the three-judge panel of the U.S. Court of Appeals for the Federal Circuit denied St. Jude's request to rehear an appeal on the "double patenting" ruling for the '439 patent. Further, it removed the injunction threat that was hanging over the... View Details
Keywords: Medical Devices; Vascular Closure Device; Patent Litigation; Patenting; Biomedical Research; Biotechnology; Biotech; Technological Innovation; Patents; Health Care and Treatment; Biotechnology Industry; United States
Hamermesh, Richard, and Lauren Barley. "Fred Khosravi and AccessClosure (C)." Harvard Business School Supplement 814-074, January 2014.
- 15 Jan 2014
- Other Presentation
Value-Based Health Care Delivery
Keywords: Health
Porter, Michael E. "Value-Based Health Care Delivery." Value-Based Health Care Seminar, Harvard Medical School, Boston, MA, January 15, 2014.
- 9 Jan 2014
- Other Presentation
Value-Based Health Care Delivery Faculty Information Session
Keywords: Health
Porter, Michael E. "Value-Based Health Care Delivery Faculty Information Session." Value-Based Health Care Seminar, Harvard Medical School, Boston, MA, January 9, 2014.
- January 2014 (Revised January 2014)
- Case
Henry Schein: Doing Well by Doing Good?
By: Rebecca Henderson, Raffaella Sadun, Aldo Sesia and Russell Eisenstat
Henry Schein Inc., a distributor of supplies to dentist, physician, and veterinary practices, had sales approaching $9 billion and employed nearly 16,000 people. The company had experienced impressive growth under the leadership of Stanley Bergman and his executive... View Details
Keywords: Leadership Development; Strategy Execution; Performance Management; Corporate Culture; Social Responsibility; Mergers & Acquisitions; Joint Ventures; Partnerships; Health Care Industry; Healthcare Logistics Industry; Competitive Advantage; Strategy; Leadership; Global Strategy; Selection and Staffing; Management Style; Organizational Culture; Corporate Social Responsibility and Impact; Health Industry; Health Industry; China; Europe; United States
Henderson, Rebecca, Raffaella Sadun, Aldo Sesia, and Russell Eisenstat. "Henry Schein: Doing Well by Doing Good?" Harvard Business School Case 714-450, January 2014. (Revised January 2014.)
- 6 Jan 2014
- Other Presentation
Value Based Health Care Delivery: Welcome and Introduction
Keywords: Health
Porter, Michael E. "Value Based Health Care Delivery: Welcome and Introduction." Value-Based Health Care Seminar, Harvard Medical School, Boston, MA, January 6, 2014.
- 6 Jan 2014
- Other Presentation
Value Based Health Care Delivery: Welcome and Introduction
Keywords: Health
Porter, Michael E. "Value Based Health Care Delivery: Welcome and Introduction." Health Care Strategy Seminar, Harvard Medical School, Boston, MA, January 6, 2014.
- 6 Jan 2014
- Other Presentation
Value-Based Health Care Delivery
Keywords: Health
Porter, Michael E. "Value-Based Health Care Delivery." Value-Based Health Care Seminar, Harvard Medical School, Boston, MA, January 6, 2014.
- January 2014 (Revised December 2014)
- Case
GenapSys: Business Models for the Genome
By: Richard G. Hamermesh, Joseph B. Fuller and Matthew Preble
GenapSys, a California-based startup, was soon to release a new DNA sequencer that the company's founder, Hesaam Esfandyarpour, believed was truly revolutionary. The sequencer would be substantially less expensive—potentially costing just a few thousand dollars—and... View Details
Keywords: DNA Sequencing; Life Sciences; Business Model; Innovation & Entrepreneurship; Health Care and Treatment; Genetics; Business Strategy; Health Industry; Health Industry; Health Industry; Health Industry; Health Industry; United States
Hamermesh, Richard G., Joseph B. Fuller, and Matthew Preble. "GenapSys: Business Models for the Genome." Harvard Business School Case 814-050, January 2014. (Revised December 2014.)
- 15 Jan 2014
- Other Presentation
Value Based Health Care Delivery: Welcome and Introduction
Keywords: Health
Porter, Michael E. "Value Based Health Care Delivery: Welcome and Introduction." Value-Based Health Care Seminar, Harvard Medical School, Boston, MA, January 15, 2014.
- December 2013 (Revised May 2021)
- Case
Paul Levy: Confronting a 'Corporate Campaign' (A)
Hospital CEO Paul Levy confronts an SEIU unionization drive via a "corporate campaign" aimed at undercutting the hospital's relationships with key internal and external constituencies. Having shepherded one of Boston's top teaching hospitals much of the way through a... View Details
Keywords: Dispute Resolution; Corporate Campaign; Negotiating Campaign; Bargaining; Health Care; Hospitals; Unions; Health Care and Treatment; Negotiation; Strategy; Negotiation Process; Labor Unions; Health Industry; Boston
Sebenius, James K. "Paul Levy: Confronting a 'Corporate Campaign' (A)." Harvard Business School Case 914-020, December 2013. (Revised May 2021.)
- January–February 2014
- Other Article
Barriers to Health Care Innovation: Regina Herzlinger Warns That Innovators Need to Know What Obstacles They Face and How to Overcome Them
Health care in the United States and in most other developed countries is ailing, says Regina E. Herzlinger. A chaired professor of business administration specializing in health care at Harvard Business School, Herzlinger says that although the world has witnessed... View Details
Keywords: Healthcare; Healthcare IT; Innovation; Health Care and Treatment; Health; Information Technology; Innovation and Invention; Health Industry; Health Industry; United States
Herzlinger, Regina E. "Barriers to Health Care Innovation: Regina Herzlinger Warns That Innovators Need to Know What Obstacles They Face and How to Overcome Them." IEEE Pulse 5, no. 1 (January–February 2014): 43–45.